Usefulness of Bcl-2 expression as a new basal cell marker in prostatic pathology;Utilidad de Bcl-2 como nuevo marcador de expresión de células basales en patología prostática

Actas Urologicas Espanolas

Volumn 30, Issue 4, 2006, Pages 345-352

  Ramos Soler, David ^a   Mayordomo Aranda, E ^a   Calatayud Blas, A ^a   Rubio Briones, J ^b   Solsona Narbon E ^b   Llombart Bosch, A ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

Author keywords

Basal cells; Bcl 2; Immunohistochemistry; Prostate cancer

Indexed keywords

EID: 33745455753     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0210-4806(06)73457-x     Document Type: Article

References (25)

1. Totten RS, Heinemann MW, Hudson PB, Sproul EE, Stout AP. Microscopic differential diagnosis of latent carcinoma of prostate. AMA Arch 1953;55:131-141.
2. Bonkhoff H. Role of the basal cells in premalignant changes of the human prostate: a stem cell concept for the development of prostate cancer. Eur Urol 1996;30:201-205.
3. Shah RB, Lakshmi PK, Shen R, LeBlanc M, Zhou M, Rubin MA. Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferation. Am J Clin Pathol 2004; 122:517-523.
4. Wu HH, Lapkus O, Corbin M. Comparison of 34betaE12 and p63 in 100 consecutive prostate carcinoma diagnosed by needle biopsies. Appl Immunohistochem Mol Morphol 2004; 12:285-289.
5. Hameed O, Sublett J, Humphrey PA. Immunohistochemical stains for p63 and alpha-methylacyl-CoA racemase, versus a cocktail comprising both in the diagnosis of prostatic carcinoma: a comparison of the immunohistochemical staining of 430 foci in radical prostatectomy and needle biopsy tissues. Am J Surg Pathol 2005;29:579-587.
6. Jiang Z, Li C. Fischer A. Dresser K, Woda BA. Using an AMACR (P504S/ 34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens. Am J Clin Pathol 2005; 123:231-236.
7. Zhou M, Aydin H, Kanane H, Epstein JI. How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers? Am J Surg Pathol 2004;28:239-243.
8. Molinie V, Herve JM, Lebret T, Lugagne-Delpon PM, Saporta F, Yonneau L, et al. Value of the antibody cocktail anti p63+anti p504S for the diagnosis of prostatic cancer. Ann Pathol 2004;24:6-16.
9. Ananthanarayanan V, Deaton RJ, Yang XJ, Pins MR, Gann PH. Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer. Prostate 2005,63:341-346.
10. Magi-Galluzzi C, Luo J, Isaacs WB, Hicks JL, de Marzo AM, Epstein JI. Alpha-methylacyl-CoA racemase: a variable sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy. Am J Surg Pathol 2003; 27:1128-1133.
11. Farinola MA, Epstein JI. Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy. Hum Pathol 2004; 35:1272-1278.
12. Montironi R, Mazzucchelli R, Stramazzotti D, Scarpelli M, Löpez-Belträn A. Bostwick D. Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. J Clin Pathol 2005:58:290-296.
13. Rehman I, Cross SS, Azzouzi AR, Catto JW, Deloulme JC, Larre S. et al. S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors. Br J Cancer 2004;91:739-744.
14. Xi Z, Klokk TI, Korkmaz K, Kurys P. Elbi C, Risberg B, et al. Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer. Cancer Res 2004; 64:2365-2370.
15. Xu J, Stolk JA, Zhang X. et al. Identification of differentially expressed genes in human prostate carcinoma using substraction and microarray. Am J Surg Pathol 2001;25:1397-1404.
16. Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase techniques. Am J Clin Pathol 1981;75:876-882.
17. Kyprianou N, Tu H, Jacobs SC. Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum Pathol 1996;27:668-675.
18. Haussler O, Epstein JI, Amin MB, Heitz PU, Hailemariam S. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia and cancer. Hum Pathol 1999;30:1077-1086.
19. Johnson MI, Robinson MC, Marsh C, Robson CN, Neal DE, Hamdy FC. Expression of Bcl-2, Bax, and p53 in high-grade prostatic intraepithelial neoplasia and localized prostate cancer-relationship with apoptosis and proliferation. Prostate 1998;37:223-229.
20. Baltaci S, Orhan D, Ozer G, Tolunay O, Gogous O. Bcl-2 proto-oncogene expression in low- and high-grade prostatic intraepithelial neoplasia. BJU Int 2000;85:155-159.
21. Wang W, Bergh A, Damber JE. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium. Prostate 2004;61:60-72.
22. Gaudin PB, Epstein JI. Adenosis of the prostate. Histologic features in needle biopsy specimens. Am J Surg Pathol 1995;19:737-747.
23. Bostwick DG, Brawer MK. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 1987; 59:788-794.
24. Zhou M, Jiang Z, Epstein JI. Expression and diagnostic utility of alpha-methylacyl-CoA racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer. Am J Surg Pathol 2003;27:772-778.
25. Magi-Galluzzi G, Luo J. Isaacs WB, Hicks JL, de Marzo AM, Epstein JI. Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy. Am J Surg Pathol 2003;27:1128-1133.